中文 | English
Return
Total: 73 , 1/8
Show Home Prev Next End page: GO
MeSH:(Carboplatin/therapeutic use*)

1.Current research analysis and prospects on sensitization effect of artesunate on anti-cancer radiotherapy and chemotherapy.

Wen-Jia CHEN ; Xia MAO ; Yan-Qiong ZHANG ; Na LIN

China Journal of Chinese Materia Medica 2019;44(23):5231-5239

2.Determination of carboplatin dose by area under the curve in combination chemotherapy for senile non-small cell lung cancer.

Tiejun, YIN ; Qingqing, LIU ; Changyao, HU

Journal of Huazhong University of Science and Technology (Medical Sciences) 2007;27(6):710-2

3.Efficacy and survival outcomes of dose-dense carboplatin plus paclitaxel as neoadjuvant chemotherapy for triple-negative breast cancer.

Yang LIU ; Meng XIU ; Xiang WANG ; Qing LI ; Jia Yu WANG ; Ying FAN ; Qiao LI ; Shan Shan CHEN ; Rui Gang CAI ; Hong Nan MO ; Fei MA ; Yang LUO ; Bing He XU ; Pin ZHANG

Chinese Journal of Oncology 2022;44(2):178-184

4.Clinical efficacy of docetaxel combined with carboplatin in patients with metastatic castration-resistant prostate cancer.

Gao Chen BAI ; Yi SONG ; Jie JIN ; Wei YU ; Zhi Song HE

Journal of Peking University(Health Sciences) 2021;53(4):686-691

5.Dose-dense paclitaxel plus carboplatin in combination with trastuzumab neoadjuvant versus standard adjuvant therapy in human epidermal growth factor receptor-2 positive and hormone receptor negative breast cancer: a prospective cohort study.

Meng XIU ; Yao LU ; Xiang WANG ; Ying FAN ; Qiao LI ; Qing LI ; Jia Yu WANG ; Yang LUO ; Rui Gang CAI ; Shan Shan CHEN ; Peng YUAN ; Fei MA ; Bing He XU ; Pin ZHANG

Chinese Journal of Oncology 2023;45(8):709-716

6.Dose-dense paclitaxel plus carboplatin in combination with trastuzumab neoadjuvant versus standard adjuvant therapy in human epidermal growth factor receptor-2 positive and hormone receptor negative breast cancer: a prospective cohort study.

Meng XIU ; Yao LU ; Xiang WANG ; Ying FAN ; Qiao LI ; Qing LI ; Jia Yu WANG ; Yang LUO ; Rui Gang CAI ; Shan Shan CHEN ; Peng YUAN ; Fei MA ; Bing He XU ; Pin ZHANG

Chinese Journal of Oncology 2023;45(8):709-716

7.Two Lung Masses with Different Responses to Pemetrexed.

Kwang Young PARK ; Jae Wook JUNG ; Seung Bum NAM ; Ho Jin LEE ; Hyo Seok KIM ; Yoon Hee CHOI ; Jae Cheol LEE

The Korean Journal of Internal Medicine 2010;25(2):213-216

8.Treatment of Radical Resected NSCLC by Chinese Medicine Combined with Adjuvant Chemother- apy: a Clinical Study.

Wan-xin HOU ; He-gen LI ; Zhi-wei CHEN ; Li-hua ZHU ; Li-hong ZHAO ; Jian-hui TIAN ; Wei-jie XU ; Lei ZHOU ; Yi-lin YAO

Chinese Journal of Integrated Traditional and Western Medicine 2015;35(6):648-653

9.A Case of Pseudomenbranous Colitis after Paclitaxel and Carboplatin Chemotherapy.

Sung Woo YANG ; Won MOON

The Korean Journal of Gastroenterology 2009;54(5):328-332

10.Ifosfamide, Cisplatin or Carboplatin, and Etoposide (ICE)-based Chemotherapy for Mobilization of Autologous Peripheral Blood Stem Cells in Patients with Lymphomas.

Ping ZHOU ; Peng LIU ; Sheng-Yu ZHOU ; Xiao-Hui HE ; Xiao-Hong HAN ; Yan QIN ; Sheng YANG ; Chang-Gong ZHANG ; Lin GUI ; Jia-Rui YAO ; Li-Ya ZHAO ; Shu-Xiang ZHANG ; Yan SUN ; Yuan-Kai SHI

Chinese Medical Journal 2015;128(18):2498-2504

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 73 , 1/8 Show Home Prev Next End page: GO